WARD Surgery RCT II

WARD Surgical Randomized Clinical Trial II (RCT)

Study design
Randomized Controlled Trial
Sample size
504 participants
Principal Investigator

Sharri Mortensen and Jesper Mølgaard

Study sites

Copenhagen University hospitals; Rigshospitalet, Bispebjerg and Hvidovre

Inclusion criteria

Cancer surgery in general anesthesia, with an expected surgical duration of more than 2 hours, and at least 2 overnight stays in the hospital after surgery

Study procedures

Continuous wireless recording of vital values with patients randomized to either no monitoring, or nurse based monitoring of a mobile phone app with vital signs displayed and alerts for sustained deviations.

Outcome

Adverse events and serious adverse events. Days alive and out of hospital.

Trial registration
NCT06269198